These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1423319

  • 1. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.
    Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, Weston A, Harris CC.
    Cancer Res; 1992 Dec 01; 52(23):6712-5. PubMed ID: 1423319
    [Abstract] [Full Text] [Related]

  • 2. An investigation of whether polymorphisms of cytochrome P4502E1 are genetic markers of susceptibility to alcoholic end-stage organ damage in a Chinese population.
    Chao YC, Young TH, Chang WK, Tang HS, Hsu CT.
    Hepatology; 1995 Nov 01; 22(5):1409-14. PubMed ID: 7590656
    [Abstract] [Full Text] [Related]

  • 3. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro.
    Hamada GS, Sugimura H, Suzuki I, Nagura K, Kiyokawa E, Iwase T, Tanaka M, Takahashi T, Watanabe S, Kino I.
    Cancer Epidemiol Biomarkers Prev; 1995 Nov 01; 4(1):63-7. PubMed ID: 7534543
    [Abstract] [Full Text] [Related]

  • 4. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
    Kato S, Shields PG, Caporaso NE, Sugimura H, Trivers GE, Tucker MA, Trump BF, Weston A, Harris CC.
    Cancer Epidemiol Biomarkers Prev; 1994 Sep 01; 3(6):515-8. PubMed ID: 8000304
    [Abstract] [Full Text] [Related]

  • 5. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to alcoholic liver cirrhosis.
    Maezawa Y, Yamauchi M, Toda G.
    Am J Gastroenterol; 1994 Apr 01; 89(4):561-5. PubMed ID: 7908498
    [Abstract] [Full Text] [Related]

  • 6. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians.
    Nishimoto IN, Hanaoka T, Sugimura H, Nagura K, Ihara M, Li XJ, Arai T, Hamada GS, Kowalski LP, Tsugane S.
    Cancer Epidemiol Biomarkers Prev; 2000 Jul 01; 9(7):675-80. PubMed ID: 10919737
    [Abstract] [Full Text] [Related]

  • 7. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].
    Wang J, Liu Z, Chen B.
    Zhonghua Yi Xue Za Zhi; 2000 Aug 01; 80(8):585-7. PubMed ID: 11798822
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1.
    Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF.
    Cancer Epidemiol Biomarkers Prev; 1998 Nov 01; 7(11):1013-8. PubMed ID: 9829710
    [Abstract] [Full Text] [Related]

  • 9. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan.
    Hildesheim A, Chen CJ, Caporaso NE, Cheng YJ, Hoover RN, Hsu MM, Levine PH, Chen IH, Chen JY, Yang CS.
    Cancer Epidemiol Biomarkers Prev; 1995 Sep 01; 4(6):607-10. PubMed ID: 8547826
    [Abstract] [Full Text] [Related]

  • 10. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
    Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, Lin DX.
    Cancer Epidemiol Biomarkers Prev; 2000 Jun 01; 9(6):551-6. PubMed ID: 10868687
    [Abstract] [Full Text] [Related]

  • 11. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
    Farker K, Lehmann MH, Oelschlägel B, Haerting J, Hoffmann A, Janitzky V, Schubert J.
    Exp Toxicol Pathol; 1998 Sep 01; 50(4-6):425-31. PubMed ID: 9784018
    [Abstract] [Full Text] [Related]

  • 12. Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis.
    Wang Y, Yang H, Li L, Wang H, Zhang C, Yin G, Zhu B.
    Eur J Cancer; 2010 Mar 01; 46(4):758-64. PubMed ID: 20031389
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite-related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population.
    Minegishi Y, Tsukino H, Muto M, Goto K, Gemma A, Tsugane S, Kudoh S, Nishiwaki Y, Esumi H.
    Cancer; 2007 Jul 15; 110(2):353-62. PubMed ID: 17559142
    [Abstract] [Full Text] [Related]

  • 14. A polymorphism in the 5'-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population.
    Iizasa T, Baba M, Saitoh Y, Suzuki M, Haga Y, Iyoda A, Chang H, Hiroshima K, Itoga S, Tomonaga T, Nomura F, Fujisawa T.
    Oncol Rep; 2005 Oct 15; 14(4):919-23. PubMed ID: 16142352
    [Abstract] [Full Text] [Related]

  • 15. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
    Nakachi K, Imai K, Hayashi S, Kawajiri K.
    Cancer Res; 1993 Jul 01; 53(13):2994-9. PubMed ID: 8319207
    [Abstract] [Full Text] [Related]

  • 16. Individual differences in lung cancer susceptibility in relation to polymorphisms of P-450IA1 gene and cigarette dose.
    Kawajiri K, Nakachi K, Imai K, Hayashi S, Watanabe J.
    Princess Takamatsu Symp; 1990 Jul 01; 21():55-61. PubMed ID: 2134690
    [Abstract] [Full Text] [Related]

  • 17. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
    Morita M, Le Marchand L, Kono S, Yin G, Toyomura K, Nagano J, Mizoue T, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Imaizumi N.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 01; 18(1):235-41. PubMed ID: 19124503
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.
    Shields PG, Ambrosone CB, Graham S, Bowman ED, Harrington AM, Gillenwater KA, Marshall JR, Vena JE, Laughlin R, Nemoto T, Freudenheim JL.
    Mol Carcinog; 1996 Nov 01; 17(3):144-50. PubMed ID: 8944074
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.